Navigation Links
World's Only FDA Approved Home Needle Destruction Device is in Production
Date:12/2/2009

WESTON, Fla., Dec. 2 /PRNewswire-FirstCall/ -- American Scientific Resources, Inc. (Pink Sheets: ASFX) (the Company), announces that the Disintegrator Plus(TM), the world's only FDA approved home needle destruction device (NDD), is in its first production run for ASR.

Specifically designed to fill the current demand for home injection prescription drug users in California (resulting from the recent passing of the SB 486 which requires Californian's to safely dispose of their sharps at home), as well as consumers throughout America and globally, the units are expected to be available during the first quarter of 2010 through various global distribution points.

The new and improved Disintegrator Plus is a safe, FDA approved device, which utilizes patented plasma arc technology to sterilize and disintegrate the needle at a temperature of over 3000 degrees Fahrenheit reducing it to a small bb-shaped ball. It uses patented technology that gives it distinct advantages over similar devices.

This "greener" version complies with the new Restriction of Hazardous Substances regulations (ROHS), a hazardous material-free directive, enforced in the European Union Communities. The new graphics and color scheme will help consumers identify this particular model as ASR's new and improved device.

In addition to already having received confirmation of a Purchase Order from a major global Pharmaceutical Corporation, ASR is creating a tactical marketing and distribution plan in order to inform municipalities, contracted waste haulers, pharmaceutical manufacturers and consumers across the world that ASR is the go-to resource for a safe, viable option to properly dispose of sharps at home.

Marc Massoglia, an Economist with extensive sales and marketing experience in B2B sales and marketing in medical devices, has been commissioned by ASR to spearhead the project.

Dr. Christopher F. Tirotta, CEO of American Scientific Resources, states, "We have a proven sales leader in Marc, enhancing our marketing and sales tactics for this device. The demand has proven the need for our product within the marketplace."

ASR is in the process of also creating a website where consumers and commercial entities can purchase the units, receive a wealth of knowledge including regulatory, education and stewardship information and also bond with a community that is familiar with challenges they face.

About American Scientific Resources, Inc.

American Scientific Resources, Inc. is the parent company for wholly-owned subsidiary, Kidz-Med, Inc. The Company's objective is to create intellectual property, as well as to locate and acquire innovative health and safety products and to introduce and promote them to the North American and Global consumer and professional healthcare market. More information about the Company, including financial information, can be found on the ASFX web site at www.americansci.com. For product information please visit www.kidzmed.com.

Safe Harbor

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.



Contact
AudioStocks.com
Ronald Garner
ron@audiostocks.com
Investor Hotline:  619-293-0621


SOURCE American Scientific Resources, Inc.


'/>"/>
SOURCE American Scientific Resources, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
2. China Biologic Products Approved to List on NASDAQ
3. eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims
4. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
5. United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food
6. Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer
7. Solos Endoscopy, Inc.s FDA Approved MammoView(TM) Product Line to Obtain CE Mark
8. Minimally Invasive Device Approved to Treat Liver Cancer, Fibroids, Tumors, and Bleeding
9. FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  M3 Biotechnology Inc., spurred by a major "team investment" by Bruce Montgomery , ... an oversubscribed Series A-Round, according to CEO Leen Kawas , PhD. ... ... ... Kawas said the ...
(Date:2/11/2016)... Calif. , Feb. 11, 2016  AcelRx Pharmaceuticals, ... podium presentation will be made at the 38th annual ... and Wound Care Symposium, which is being held February ... international conference covers the latest advancements in wound healing, ... the American Burn Association, Australian-New Zealand Burns Association, Academy ...
(Date:2/11/2016)... TEL AVIV, Israel , Feb. 11, 2016  Galmed ... clinical-stage biopharmaceutical company focused on the development of a ... announced today that its Chief Medical Officer, Dr. ... retiring from Galmed as Chief Medical Officer and from ... 2016 due to her reaching retirement age. ...
Breaking Medicine Technology:
(Date:2/11/2016)... , ... February 11, 2016 , ... ... J.R. Garrett Esq. as General Counsel. Garrett will focus on contract negotiations, corporate ... audits, privacy and security law, and best practices in data breaches for the ...
(Date:2/11/2016)... ... February 11, 2016 , ... AccuVein Inc. ... Infusion Therapy Standards of Practice, to include vascular visualization as a standard practice. ... 85% share of the market, facilitates adherence to this standard with its easy ...
(Date:2/11/2016)... ... ... The annual list showcases the 20 Most Promising SharePoint Solution Providers in 2015. ... to the SharePoint ecosystem. A panel of experts and members of CIOReview’s editorial board ... promote technology entrepreneurship. , The survey was made at the end of the ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... dynamometers and ergoFET force gauges used in physical therapy, occupational therapy and sports ... sensor for resistance cord exercise and therapy, introduces its new microFET Digital Pinch ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... coverage results in significantly higher rates of several common cancer screenings, especially among ... in better outcomes and survival rates. , The study,“What Does Medicaid Expansion ...
Breaking Medicine News(10 mins):